Comparison Between Bronchoscopy and Real- Time Ultrasound Guided Percutaneous Tracheostomy

March 9, 2020 updated by: Aykut Saritas

Comparison Between Bronchoscopy and Real- Time Ultrasound Guided Percutaneous Dilatational Tracheostomy for Safety, Complications and Efficiency in Critically Ill Patient

Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.

Study Overview

Detailed Description

Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.

Patients will be randomly assigned to be submitted to evaluate safety, complication rates, easy to perform , clinical outcomes and effectivity.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All intubated and mechanically ventilated patients indicated for a tracheostomy

Exclusion Criteria:

  • Patients with tracheal or neck abnormalities, soft tissue infection in the neck, neck surgery history, oxygenation problems , coagulation disorders or coagulation parameter changes and those requiring urgent or surgery patients unable to provide informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ultrasound
Ultrasound guided percutaneous tracheostomy
Ultrasound guided percutaneous tracheostomy
Active Comparator: Bronchoscopy
Bronchoscopy guided percutaneous tracheostomy
Bronchoscopy guided percutaneous tracheostomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
procedure failure of ultrasound to provide this anatomical information and ease of perform
Time Frame: During percutaneous tracheostomy an expected average time 20 minutes
occurence of a major complications: bleeding, subcutaneous emphysema, oesophageal perforation, number of applied needle interventions, procedure duration, cardiorespiratory arrest
During percutaneous tracheostomy an expected average time 20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
procedure time
Time Frame: during percutaneous tracheostomy ( average expected time 20 minutes)
the procedure duration was taken as the time that elapsed from the placement of the needle to the placement of the tracheostomy cannula.
during percutaneous tracheostomy ( average expected time 20 minutes)
Pneumothorax
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Pneumothorax due to the percutaneous tracheostomy detected by clinical examination during the procedure or chest x-ray after the procedure.
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Tracheal posterior wall injury
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Tracheal posterior wall injury as detected by bronchoscopy after the procedure
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Accidental decannulation
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Accidental decannulation after the procedure during Hospital stay
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Cardiorespiratory arrest
Time Frame: during percutaneous tracheostomy an expected average of 20 minutes
Cardiorespiratory arrest due to percutaneous tracheostomy
during percutaneous tracheostomy an expected average of 20 minutes
Minor bleeding
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Haemorrhage that could not be stopped by sponge wrapping the stoma after the procedure and/or blood coming with aspiration inside the tracheostomy tube was defined as minor bleeding
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Major bleeding
Time Frame: During the procedure an expected average of 20 minutes
Continuous haemorrhage from the stoma and/or from the trachea with aspiration despite compresses was defined as a major haemorrhage.
During the procedure an expected average of 20 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hypoxemia
Time Frame: During percutaneous tracheostomy an expected average of 20 minutes
Drop in peripheral oxygen saturation < 90% for more than 2 minutes as measured by pulse oximeter during the procedure
During percutaneous tracheostomy an expected average of 20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Aykut Saritas, MD, Izmir Tepecik Training and Research Hospital
  • Study Chair: muhammed murat kurnaz, MD, Prof.Dr.A.İlhan Ozdemir State hospital Giresun

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

September 1, 2016

Study Registration Dates

First Submitted

January 5, 2016

First Submitted That Met QC Criteria

January 14, 2016

First Posted (Estimate)

January 15, 2016

Study Record Updates

Last Update Posted (Actual)

March 10, 2020

Last Update Submitted That Met QC Criteria

March 9, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2014-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tracheostomy Complications

Clinical Trials on Ultrasound guided percutaneous tracheostomy

Subscribe